BIOCIUS Life Sciences logo — Engaging in innovative drug discovery research since 2009, o...

BIOCIUS Life Sciences

Engaging in innovative drug discovery research since 2009, operating from Woburn, Massachusetts as a proud subsidiary of a renowned parent company.

Founded 2009 11-50 employees Private Equity Biotechnology, Health Care

General Information

Company Name BIOCIUS Life Sciences
Founded Year 2009
Employees 11-50
Industries Biotechnology, Health Care
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with BIOCIUS Life Sciences. To contact BIOCIUS Life Sciences, visit biocius.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BIOCIUS Life Sciences compare?

A PDF of BIOCIUS Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BIOCIUS Life Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BIOCIUS Life Sciences

BIOCIUS Life Sciences, founded in 2009, is a prominent player in the Biotechnology and Health Care industries. The company, with its slogan "Engaging in innovative drug discovery research since 2009, operating from Woburn, Massachusetts as a proud subsidiary of a renowned parent company," is committed to advancing drug discovery research. BIOCIUS specializes in utilizing RapidFire® technology to facilitate lead discovery and in vitro ADME, effectively eliminating bottlenecks in the process. The RapidFire system, incorporating high-throughput mass spectrometry (MS), enables comprehensive understanding of potential lead compounds, including potential liabilities in drug-drug interactions. This innovative technology, built on microfluidics and automation, is 10 to 100 times faster than traditional MS screening methods, without requiring labels or surrogates. The capability to screen challenging targets has promising implications for clinical sample analysis such as blood, plasma, urine, food, and pesticides. Furthermore, the system seamlessly integrates with most mass spectrometry systems and is marketed for Agilent and AB/Sciex. The last investment, a Private Equity Round at 01 January 2015, featured investments from Excel Venture Management and CB Health Ventures. Overall, BIOCIUS's innovative approach and strategic partnerships make it an intriguing prospect for investors in the life sciences space.

Business keywords: Innovative drug discovery, Pharmaceutical research, High-throughput screening, In Vitro ADME, Biotech subsidiary, Woburn, Massachusetts, Biotech startups, Biotech investments

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 2
Excel Venture Management, CB Health Ventures
01 Jan 2015
Venture Round Undisclosed 1
Catalyst Health Ventures
01 Jan 2012

BIOCIUS Life Sciences Alternatives & Competitors

View All Alternatives
BIOCIUS Life Sciences vs

Empowering genomic research and drug discovery with micro and nano-scale technology platforms for im...

Series C
Biotechnology, Health Care
BIOCIUS Life Sciences vs

Boundless GPCR drug discovery

Seed
3 employees
Biotechnology, Health Care
BIOCIUS Life Sciences vs

Empowering life sciences with advanced proteomic and genomic solutions for improved drug development...

Seed
Biotechnology, Health Care

FAQ About BIOCIUS Life Sciences

Engaging in innovative drug discovery research since 2009, operating from Woburn, Massachusetts as a proud subsidiary of a renowned parent company.
BIOCIUS Life Sciences was founded in 2009.
BIOCIUS Life Sciences operates in Biotechnology and Health Care. Its work centres on Innovative drug discovery, Pharmaceutical research, High-throughput screening and In Vitro ADME.
BIOCIUS Life Sciences has approximately 11-50 employees.
BIOCIUS Life Sciences has completed 2 funding rounds. The latest funding stage is Private Equity.
Top alternatives and competitors to BIOCIUS Life Sciences include BioTrove, Design Pharmaceuticals Inc., Courtagen Life Sciences, Altis Biosystems, DELIVER Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOCIUS Life Sciences and BioTrove are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BIOCIUS Life Sciences, https://bouncewatch.com/company/biocius-life-sciences, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes